Comparison between liposomal formulations of amphotericin B.

@article{AdlerMoore2016ComparisonBL,
  title={Comparison between liposomal formulations of amphotericin B.},
  author={Jill P. Adler-Moore and J. P. Gangneux and Peter G. Pappas},
  journal={Medical mycology},
  year={2016},
  volume={54 3},
  pages={223-31}
}
Given the clinical success of commercial amphotericin B lipid products, investigators have begun making generic formulations of liposomal amphotericin B. Generic medicines are an attractive approach to help decrease the cost and accessibility to healthcare, provided that appropriate studies are performed to ensure bioequivalence with the parent product. This is of particular concern for liposomal drugs such as amphotericin B where liposomes are used as a carrier system to reduce the toxicity of… CONTINUE READING
Recent Discussions
This paper has been referenced on Twitter 3 times over the past 90 days. VIEW TWEETS

From This Paper

Figures, tables, results, connections, and topics extracted from this paper.
8 Extracted Citations
54 Extracted References
Similar Papers

Citing Papers

Publications influenced by this paper.
Showing 1-8 of 8 extracted citations

Referenced Papers

Publications referenced by this paper.
Showing 1-10 of 54 references

Similar Papers

Loading similar papers…